A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Mike Putman EBRheum
7 years 6 months ago
Following along with #RNL2019 for free! Very slick format. Dr. Conaghan echoing my recent thoughts on U/S from Episode 32 on TaSER and ARCTIC trials: don't use for TtT, but important role when diagnosis uncertain and has prognostic value. @UltrasoundRheum @uptoTate @RheumNow https://t.co/mnweGvGkaw
Dr. John Cush RheumNow
7 years 6 months ago
Dr Phil Conaghan on the similarity between OA and PsA #RNL2019 https://t.co/za9YDAWilE
Dima Nimri Dima_Nimri
7 years 6 months ago
Took away so much from #RNL2019, but most importantly took a photo with the Godfather of rheumatology @RheumNow! #celebritiesinrheumatology https://t.co/EvXrUXJUGc
Dr. John Cush RheumNow
7 years 6 months ago
The genetics of ANKYLOSING SPONDYLITIS. #RNL2019 - Dr. John Reveille https://t.co/wIszzNqU01
Dr. John Cush RheumNow
7 years 6 months ago
Dr Carol Langford lecturing at S Carolina Rheum Assn. 1) EGPA usually ANCA negative. 2) a +ANCA does not = a Dx of Vasculitis. 3) +ANCA has a predictive value=90% if renal dz present; but PPV down to 30-60% if only sinus & pulmonary dz present. https://t.co/RfIQEUliRb
QD Clinic - Who’s the Boss
Instructions for Patients Going to the Hospital
Dr. John Cush RheumNow
7 years 6 months ago
340 CCP+ persons without followed for 1047 PYrs = 21.5% developed RA. Risk of RA progression increased w/ CCP level. 46.0% of high level CCP patients progressedto RA by 5 years. High vs low CCP were 5 times more likely to get RA (HR 4.83, 95%CI 2.51-9.31). https://t.co/V3cRnMzerw
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.
Dr. John Cush RheumNow
7 years 6 months ago
QD Clinic - Give them an inch... Patients with the urge to change their meds | RheumNow - https://t.co/GZfy9HJ55q
QD Clinic - Give them an inch...
Patients with the urge to change their meds
Patients with rheumatoid arthritis (RA) who also had chronic obstructive pulmonary disease (COPD) had no increased risk of serious respiratory complications when treated with abatacept (Orencia), a large claims-based analysis found.
